Paradigm Biopharmaceuticals Ltd
ASX:PAR

Watchlist Manager

Paradigm Biopharmaceuticals Ltd

ASX:PAR

Watchlist

Dividends

Discount Rate

Price: 0.39 AUD -2.5% Market Closed

Market Cap: 136.3m AUD

Have any thoughts about
Paradigm Biopharmaceuticals Ltd?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

Add Price Alert

Price Target:

Last Price: 0.39 AUD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

PAR Alert

Paradigm Biopharmaceuticals Ltd

0.39

-0.01 (-2.5%)

52 Week Range	0.175 0.58
Price Target

We'll email you a reminder when the closing price reaches AUD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Paradigm Biopharmaceuticals Ltd

What unique competitive advantages
does Paradigm Biopharmaceuticals Ltd hold over its rivals?

What risks and challenges
does Paradigm Biopharmaceuticals Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Paradigm Biopharmaceuticals Ltd.

What unique competitive advantages
does Paradigm Biopharmaceuticals Ltd hold over its rivals?

What risks and challenges
does Paradigm Biopharmaceuticals Ltd face in the near future?

Has there been any significant insider trading activity
in Paradigm Biopharmaceuticals Ltd recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Paradigm Biopharmaceuticals Ltd.

Provide P/S
for Paradigm Biopharmaceuticals Ltd.

Provide P/E
for Paradigm Biopharmaceuticals Ltd.

Provide P/OCF
for Paradigm Biopharmaceuticals Ltd.

Provide P/FCFE
for Paradigm Biopharmaceuticals Ltd.

Provide P/B
for Paradigm Biopharmaceuticals Ltd.

Provide EV/S
for Paradigm Biopharmaceuticals Ltd.

Provide EV/GP
for Paradigm Biopharmaceuticals Ltd.

Provide EV/EBITDA
for Paradigm Biopharmaceuticals Ltd.

Provide EV/EBIT
for Paradigm Biopharmaceuticals Ltd.

Provide EV/OCF
for Paradigm Biopharmaceuticals Ltd.

Provide EV/FCFF
for Paradigm Biopharmaceuticals Ltd.

Provide EV/IC
for Paradigm Biopharmaceuticals Ltd.

Show me price targets
for Paradigm Biopharmaceuticals Ltd made by professional analysts.

What are the Revenue projections
for Paradigm Biopharmaceuticals Ltd?

How accurate were the past Revenue estimates
for Paradigm Biopharmaceuticals Ltd?

What are the Net Income projections
for Paradigm Biopharmaceuticals Ltd?

How accurate were the past Net Income estimates
for Paradigm Biopharmaceuticals Ltd?

What are the EPS projections
for Paradigm Biopharmaceuticals Ltd?

How accurate were the past EPS estimates
for Paradigm Biopharmaceuticals Ltd?

What are the EBIT projections
for Paradigm Biopharmaceuticals Ltd?

How accurate were the past EBIT estimates
for Paradigm Biopharmaceuticals Ltd?

Compare the revenue forecasts
for Paradigm Biopharmaceuticals Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Paradigm Biopharmaceuticals Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Paradigm Biopharmaceuticals Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Paradigm Biopharmaceuticals Ltd compared to its peers.

Compare the P/E ratios
of Paradigm Biopharmaceuticals Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Paradigm Biopharmaceuticals Ltd with its peers.

Analyze the financial leverage
of Paradigm Biopharmaceuticals Ltd compared to its main competitors.

Show all profitability ratios
for Paradigm Biopharmaceuticals Ltd.

Provide ROE
for Paradigm Biopharmaceuticals Ltd.

Provide ROA
for Paradigm Biopharmaceuticals Ltd.

Provide ROIC
for Paradigm Biopharmaceuticals Ltd.

Provide ROCE
for Paradigm Biopharmaceuticals Ltd.

Provide Gross Margin
for Paradigm Biopharmaceuticals Ltd.

Provide Operating Margin
for Paradigm Biopharmaceuticals Ltd.

Provide Net Margin
for Paradigm Biopharmaceuticals Ltd.

Provide FCF Margin
for Paradigm Biopharmaceuticals Ltd.

Show all solvency ratios
for Paradigm Biopharmaceuticals Ltd.

Provide D/E Ratio
for Paradigm Biopharmaceuticals Ltd.

Provide D/A Ratio
for Paradigm Biopharmaceuticals Ltd.

Provide Interest Coverage Ratio
for Paradigm Biopharmaceuticals Ltd.

Provide Altman Z-Score Ratio
for Paradigm Biopharmaceuticals Ltd.

Provide Quick Ratio
for Paradigm Biopharmaceuticals Ltd.

Provide Current Ratio
for Paradigm Biopharmaceuticals Ltd.

Provide Cash Ratio
for Paradigm Biopharmaceuticals Ltd.

What is the historical Revenue growth
over the last 5 years for Paradigm Biopharmaceuticals Ltd?

What is the historical Net Income growth
over the last 5 years for Paradigm Biopharmaceuticals Ltd?

What is the current Free Cash Flow
of Paradigm Biopharmaceuticals Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Paradigm Biopharmaceuticals Ltd.

Section:

Dividends

Paradigm Biopharmaceuticals Ltd

does not pay dividends

Shareholder Yield

Current shareholder yield for PAR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield

= Dividend Yield

+ Buyback Yield

+ Debt Paydown Yield

Shareholder Yield

Use Debt Paydown Yield

Dividend Yield

No dividends

Buyback Yield

Lowest

Average

Highest

Debt Paydown Yield

Lowest

Average

Highest

Peers Comparison
Shareholder Yield

Use Debt Paydown Yield

	Company	Total Yield	Dividend Yield	Buyback Yield	Debt Paydown Yield

Buybacks

Buyback Yield
Paradigm Biopharmaceuticals Ltd

Period

10Y

15Y

30Y

Yield Statistics, Past 5 Years

Min

Max

Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Buybacks

	Company	Buyback Yield	Average Yield (3Y)	Average Yield (5Y)	Average Yield (10Y)

Debt Paydown

Debt Paydown Yield
Paradigm Biopharmaceuticals Ltd

Period

10Y

15Y

30Y

Yield Statistics, Past 5 Years

Min

Max

Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Debt Paydown

	Company	Debt Paydown Yield	Average Yield (3Y)	Average Yield (5Y)	Average Yield (10Y)

Price Appreciation

PAR Price
Paradigm Biopharmaceuticals Ltd

1M 1M

-15%

6M 6M

+59%

1Y 1Y

-6%

3Y 3Y

-80%

5Y 5Y

-86%

10Y 10Y

+8%

Annual Price Range

0.39

52w Low

0.175

52w High

0.58

Price Metrics

Average Annual Return	-15.51%
Standard Deviation of Annual Returns	12.99%
Max Drawdown	-96%

Shares Statistics

Market Capitalization	136.6m AUD
Shares Outstanding	349 427 000
Percentage of Shares Shorted	N/A

PAR Return Decomposition
Main factors of price return

What is price return decomposition?

	Franklin Covey Co NYSE:FC	36.41 USD -1.03%
	Mohawk Industries Inc NYSE:MHK	119.16 USD 2%
	Ardmore Shipping Corp NYSE:ASC	11.31 USD 0.18%
	ASGN Inc NYSE:ASGN	83.87 USD -0.97%
	Skyworks Solutions Inc NASDAQ:SWKS	88.75 USD 0.56%
	Weatherford International PLC NASDAQ:WFRD	67.1 USD -2.13%

	Johnson & Johnson NYSE:JNJ	144.47 USD 0.62%
	Bank of America Corp NYSE:BAC	44.17 USD 1.82%
	Mastercard Inc NYSE:MA	528.03 USD 0.91%
	Salesforce Inc NYSE:CRM	343.65 USD 2.21%
	Abbvie Inc NYSE:ABBV	175.58 USD 2.37%
	Home Depot Inc NYSE:HD	392.6 USD 1.97%

	Arista Networks Inc NYSE:ANET	112.81 USD 3.43%
	Visa Inc NYSE:V	317.71 USD 0.9%
	Texas Pacific Land Corp NYSE:TPL	1 133.12 USD 3.36%
	KLA Corp NASDAQ:KLAC	629.37 USD 1.16%
	Manhattan Associates Inc NASDAQ:MANH	280.26 USD -0.81%
	Pinduoduo Inc NASDAQ:PDD	99.51 USD -1.48%

	Salesforce Inc NYSE:CRM	343.65 USD 2.21%
	Accenture PLC NYSE:ACN	366.37 USD -1.56%
	ServiceNow Inc NYSE:NOW	1 091.25 USD 1.52%
	EOG Resources Inc NYSE:EOG	119.04 USD 0.69%
	Copart Inc NASDAQ:CPRT	58.22 USD -0.39%
	Applied Materials Inc NASDAQ:AMAT	163.59 USD 1.33%

Paradigm Biopharmaceuticals Ltd
ASX:PAR

Dividends

Shareholder Yield

Peers Comparison
Shareholder Yield

Buybacks

Buyback Yield
Paradigm Biopharmaceuticals Ltd

Peers Comparison
Buybacks

Debt Paydown

Debt Paydown Yield
Paradigm Biopharmaceuticals Ltd

Peers Comparison
Debt Paydown

Price Appreciation

PAR Price
Paradigm Biopharmaceuticals Ltd

PAR Return Decomposition
Main factors of price return

See Also

Company

Help

Tools

Stocks

	ePlus inc NASDAQ:PLUS	74 USD 0.14%
	Paradigm Biopharmaceuticals Ltd ASX:PAR	0.39 AUD -2.5%

Paradigm Biopharmaceuticals Ltd ASX:PAR

Dividends

Shareholder Yield

Peers Comparison Shareholder Yield

Buybacks

Buyback Yield Paradigm Biopharmaceuticals Ltd

Peers Comparison Buybacks

Debt Paydown

Debt Paydown Yield Paradigm Biopharmaceuticals Ltd

Peers Comparison Debt Paydown

Price Appreciation

PAR Price Paradigm Biopharmaceuticals Ltd

PAR Return Decomposition Main factors of price return

See Also

Company

Help

Tools

Stocks

Paradigm Biopharmaceuticals Ltd
ASX:PAR

Peers Comparison
Shareholder Yield

Buyback Yield
Paradigm Biopharmaceuticals Ltd

Peers Comparison
Buybacks

Debt Paydown Yield
Paradigm Biopharmaceuticals Ltd

Peers Comparison
Debt Paydown

PAR Price
Paradigm Biopharmaceuticals Ltd

PAR Return Decomposition
Main factors of price return